- Home
- IRWD vs EU Comparison
IRWD vs EU Comparison
Compare IRWD & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- EU
- Stock Information
- Founded
- IRWD 1998
- EU 2009
- Country
- IRWD United States
- EU United States
- Employees
- IRWD N/A
- EU N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- IRWD Health Care
- EU Basic Materials
- Exchange
- IRWD Nasdaq
- EU Nasdaq
- Market Cap
- IRWD 734.5M
- EU 606.1M
- IPO Year
- IRWD 2010
- EU N/A
- Fundamental
- Price
- IRWD $3.66
- EU $3.32
- Analyst Decision
- IRWD Buy
- EU Strong Buy
- Analyst Count
- IRWD 4
- EU 2
- Target Price
- IRWD $12.00
- EU $6.50
- AVG Volume (30 Days)
- IRWD 2.4M
- EU 1.5M
- Earning Date
- IRWD 02-13-2025
- EU 11-14-2024
- Dividend Yield
- IRWD N/A
- EU N/A
- EPS Growth
- IRWD N/A
- EU N/A
- EPS
- IRWD N/A
- EU N/A
- Revenue
- IRWD $378,418,000.00
- EU $44,972,063.00
- Revenue This Year
- IRWD N/A
- EU N/A
- Revenue Next Year
- IRWD N/A
- EU $65.28
- P/E Ratio
- IRWD N/A
- EU N/A
- Revenue Growth
- IRWD N/A
- EU N/A
- 52 Week Low
- IRWD $3.06
- EU $3.02
- 52 Week High
- IRWD $15.70
- EU $5.05
- Technical
- Relative Strength Index (RSI)
- IRWD 40.23
- EU 43.40
- Support Level
- IRWD $3.56
- EU $3.26
- Resistance Level
- IRWD $3.88
- EU $3.46
- Average True Range (ATR)
- IRWD 0.31
- EU 0.17
- MACD
- IRWD -0.10
- EU -0.01
- Stochastic Oscillator
- IRWD 10.40
- EU 14.20
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.